PPA
ABUS icon

Parametric Portfolio Associates’s Arbutus Biopharma ABUS Stock Holding History

Parametric Portfolio Associates’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$509K Buy
170,798
+157,240
+1,160% +$481K ﹤0.01% 3090
2021
Q4 		$53K Buy
+13,558
New +$52.7K ﹤0.01% 3593
2018
Q4 		– Sell
-105,617
Closed -$998K – 3900
2018
Q3 		$998K Buy
+105,617
New +$1.05M ﹤0.01% 3098
2014
Q2 		– Sell
-35,569
Closed -$764K – 3722
2014
Q1 		$764K Buy
+35,569
New +$639K ﹤0.01% 2888

Other funds holding ABUS

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $16.6B AUM 30.2% 1-Year Est. Return
BC
Brookfield Corp Toronto, Ontario, Canada $74.2B AUM 0.68% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $2.17B AUM 169.27% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return